Japanese researchers initiated Phase I human trials of a tooth-regrowing drug, TRG-035, at Kyoto University Hospital in October 2024, targeting USAG-1 protein inhibition. With 30 participants, the trials aim for commercial readiness by 2030. While promising, experts caution that significant challenges remain before widespread availability.

KEY POINTS: • The United States officially withdrew from the World Health Organization on January 22, 2026, one year after President Trump signed Executive Order...

Alphabet has reached a $4 trillion market valuation, joining Nvidia, Microsoft, and Apple. The company's stock rose significantly after Apple announced a partnership to utilize Google's Gemini AI models for its services. Alphabet's strong performance has been bolstered by advancements in AI technology and growth in its cloud business, surpassing Apple in market capitalization.

Warner Music Group settled its copyright lawsuit against Suno, marking the first major label partnership with the AI company, which has secured $250 million in funding. Meanwhile, Universal Music Group and Sony Music continue litigation against Suno for alleged copyright infringement, raising discussions on the future of AI in music.

KEY POINTS: • China's first atomic quantum computer, Hanyuan-1, has entered commercial use with orders exceeding 40 million yuan ($5.6 million), according to the South...

KEY POINTS: • The United States officially withdrew from the World Health Organization on January 22, 2026, one year after President Trump signed Executive Order...

Alphabet has reached a $4 trillion market valuation, joining Nvidia, Microsoft, and Apple. The company's stock rose significantly after Apple announced a partnership to utilize Google's Gemini AI models for its services. Alphabet's strong performance has been bolstered by advancements in AI technology and growth in its cloud business, surpassing Apple in market capitalization.

Warner Music Group settled its copyright lawsuit against Suno, marking the first major label partnership with the AI company, which has secured $250 million in funding. Meanwhile, Universal Music Group and Sony Music continue litigation against Suno for alleged copyright infringement, raising discussions on the future of AI in music.